Health Condition 1: B353- Tinea pedis
Conditions
Interventions
Intervention1: habb Kibreet and zimaad: Habbe Kibreet Sagheer and Zimad in Comparison with Itraconazole and clotrimazole in Tinea Pedis.Habbe kibreet sagheer
500 mg BD will be administrated orally (af
Sponsors
National Institute Of Unani medicine
Eligibility
Inclusion criteria
Inclusion criteria: 1.Clinically and microscopically diagnosed patient of Tinea Pedis 2.Subjects of all genders 3.Age group 15-60 years 4.Subjects who have agreed to sign the informed consent form 5.All four types of Tinea Pedis include
Exclusion criteria
Exclusion criteria: 1.Subjects below 15 years and 60 years of age 2.Pregnant and lactating women 3.Subjects with a history of systemic and metabolic disorder 4.Subject with a history of uncontrolled Diabetes, HIV/AIDS, or Immunocompromised patient 5.Subjects with concomitant skin diseases like eczema, psoriasis, and onychomycosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1)Negative KOH scraping 2)Change in photography of lesions Timepoint: 0th (baseline),7th Day,14th Day,21st Day,28th Day,35th Day. | — |
Secondary
| Measure | Time frame |
|---|---|
| • Decrease in TSSTimepoint: 0th (baseline),7th Day,14th Day 21st Day,28th Day,35th Day | — |
Countries
India
Contacts
Public ContactProf Mohd Aleemuddin Quamri
National Institute Of Unani Medicine
Outcome results
None listed